gabexate has been researched along with Constriction, Pathologic in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, M | 1 |
| Tanaka, I | 1 |
| Fujimura, M | 1 |
| Matsuda, T | 1 |
1 other study available for gabexate and Constriction, Pathologic
| Article | Year |
|---|---|
[A case of broncho-constriction induced by gabexate mesilate].
Topics: Adult; Bronchial Diseases; Constriction, Pathologic; Gabexate; Humans; Male; Serine Proteinase Inhib | 1996 |